Finance

Lists
Why is ENTA up 3.07%?
Dive Deeper
ENTA:NASDAQ
Enanta Pharmaceuticals Inc
$11.76
+3.07%
(+0.35) 1D
Oct 20, 2:33:44 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTA...
Open
$11.43
High
$11.85
Low
$11.41
Mkt. cap
342.51M
Avg. vol.
268.00K
Volume
99.22K
52-wk high
$17.15
52-wk low
$10.20
EPS
-$2.41
Beta
0.96
Shares outstanding
29.12M
No. of employees
120
Open
$11.43
High
$11.85
Low
$11.41
Mkt. cap
342.51M
Avg. vol.
268.00K
Volume
99.22K
52-wk high
$17.15
52-wk low
$10.20
EPS
-$2.41
Beta
0.96
Shares outstanding
29.12M
No. of employees
120
News stories
From web sources and news partners
About Enanta Pharmaceuticals Inc
CEO-
Employees120
Founded1995
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websiteenanta.com
Analyst ratings
Based on 1 analyst giving stock ratings to ENTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ENTA in the last 3 months
Highest
Current $11.76
$20.00 (+70.07%)
Average
$20.00 (+70.07%)
Lowest
$20.00 (+70.07%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$20.00
+70.1%
09/23/2026
Unknown Analyst
Rodman & Renshaw
Buy
Initiated
$20.00
+70.1%
03/26/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
$19.00
+61.6%
03/03/2026
Last report
Aug 10, 2026
Fiscal period
Q3 2026
-$0.67 / -$0.54
-25.23%miss
Revenue / Est. (USD)
14.36M / 16.37M
-12.28%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
15.12M
18.62M
17.16M
14.36M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23.81M
20.86M
19.44M
22.13M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.70M
9.01M
9.57M
9.47M
Operating expense
33.51M
29.87M
29.01M
31.60M
Total operating expenses
33.51M
29.87M
29.01M
31.60M
Operating income
-18.39M
-11.25M
-11.85M
-17.24M
Other non operating income
39.00K
-
-
-
EBT including unusual items
-18.67M
-11.91M
-13.08M
-19.46M
EBT excluding unusual items
-19.63M
-11.89M
-13.08M
-19.46M
Income tax expense
32.00K
24.00K
7.00K
36.00K
Effective tax rate
-0.17%
-0.20%
-0.05%
-0.18%
Other operating expenses
-
-
-
-
Net income
-18.70M
-11.94M
-13.09M
-19.50M
Net profit margin
-123.64%
-64.13%
-76.29%
-135.81%
Earnings per share
-0.87
-0.42
-0.45
-0.67
Interest and investment income
1.11M
2.44M
2.08M
1.90M
Interest expense
-2.39M
-3.08M
-3.32M
-4.13M
Net interest expenses
-1.28M
-641.00K
-1.23M
-2.23M
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.10M
-10.02M
-10.64M
-16.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps